Swiss germ-cell cancer consensus recommendations.

Details

Ressource 1Download: smw_151_w30023.pdf (611.31 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-SA 4.0
Serval ID
serval:BIB_632D6763E6AD
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Swiss germ-cell cancer consensus recommendations.
Journal
Swiss medical weekly
Author(s)
Beyer J., Berthold D., Bode P.K., Cathomas R., Fankhauser C.D., Fischer S., Gillessen S., Gross T., Hermanns T., Honecker F., Lorch A., Omlin A., Papachristofilou A., Roth B., Rothermundt C., Seiler R., Spahn M., Stenner F., Bührer E.
ISSN
1424-3997 (Electronic)
ISSN-L
0036-7672
Publication state
Published
Issued date
23/08/2021
Peer-reviewed
Oui
Volume
151
Number
33-34
Pages
w30023
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
Abstract
Approximately 420 men are diagnosed with germ-cell cancer (GCC) in Switzerland each year. Recent international guidelines outline management issues, but many aspects remain controversial in an area of highly individualised treatments. Even more than in other tumour types, in GCC the challenge is to choose exactly the correct treatment for an individual patient. Overtreatment in patients likely to be cured must be avoided to reduce long-term toxicities. On the other hand, treatment intensification is required in patients presenting with adverse prognostic factors. Therefore, referral to expert centres or consultations with an expert for a second opinion is strongly recommended. In 2020, Swiss experts discussed their strategies in a consensus meeting during the virtual Swiss Oncology and Haematology Congress (SOHC) in order to harmonise their concepts and to suggest optimal strategies for the management of GCC patients in Switzerland. Votes on controversial issues were obtained and are presented in this review wherever applicable.
Pubmed
Open Access
Yes
Create date
04/10/2021 12:13
Last modification date
13/08/2022 6:10
Usage data